or Try an Advanced Search...

    Biopharmaceutical Development Stocks List

    Symbol Grade Name % Change
    IQV F IQVIA Holdings, Inc. 1.62
    MRVI F Maravai LifeSciences Holdings, Inc. 0.67
    BLRX F BioLineRx Ltd. 3.88
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Biotechnology Life Sciences Acid Acute Myeloid Leukemia Antibody Assay Development Services Autoimmune Disease Biology Biopharmaceutical Biopharmaceutical Products Central Nervous System Disease Chemical Synthesis Clinical Development Clinical Research Clinical Trial Compugen Drug Discovery Drug Therapies Gene Therapy Genscript Biotech

    Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical Development stocks.

    Symbol Grade Name Weight
    EKG D First Trust Nasdaq Lux Digital Health Solutions ETF 6.92
    LGHT D Langar Global HealthTech ETF 6.5
    BBH D Market Vectors Biotech ETF 4.98
    IBB C iShares Nasdaq Biotechnology Index Fund 4.13
    EDOC B Global X Telemedicine & Digital Health ETF 3.22
    View all Biopharmaceutical Development ETFs...
    Compare ETFs
    Compare BBH to EDOC Compare BBH to IBB Compare EKG to EDOC

        Biopharmaceutical Development Stocks Recent News

        Date Stock Title
        Nov 1 IQV IQVIA Holdings Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Nov 1 IQV IQVIA Holdings Inc (IQV) Q3 2024 Earnings Call Highlights: Strong EPS Growth Amid Market Challenges
        Nov 1 IQV Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight
        Nov 1 IQV Q3 2024 IQVIA Holdings Inc Earnings Call
        Nov 1 IQV IQVIA (IQV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
        Oct 31 IQV IQVIA Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript
        Oct 31 IQV IQVIA Earnings & Revenues Surpass Estimates in Q3, Increase Y/Y
        Oct 31 IQV Veeva Systems Collaborates With Walgreens to Improve Patient Outcomes
        Oct 31 IQV IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates
        Oct 31 IQV IQVIA Non-GAAP EPS of $2.84 beats by $0.03, revenue of $3.89B beats by $30M
        Oct 31 IQV IQVIA: Q3 Earnings Snapshot
        Oct 31 IQV IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day
        Oct 30 IQV IQVIA Q3 2024 Earnings Preview
        Oct 30 IQV IQVIA Holdings Inc. (IQV): Among UBS’ Top Tech Based Disruptive Stocks For 2030
        Oct 28 IQV IQVIA Gears Up to Report Q3 Earnings: Here's What You Should Know
        Oct 28 IQV Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
        Oct 28 IQV Seeking Clues to IQVIA (IQV) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Biotechnology Life Sciences Acid Acute Myeloid Leukemia Antibody Assay Development Services Autoimmune Disease Biology Biopharmaceutical Biopharmaceutical Products Central Nervous System Disease Chemical Synthesis Clinical Development Clinical Research Clinical Trial Compugen Drug Discovery Drug Therapies Gene Therapy Genscript Biotech
        Biopharmaceutical Development

        Biopharmaceutical development is the process of developing biopharmaceuticals, which are drugs derived from biological sources. This process involves the identification of a target molecule, the development of a drug candidate, and the clinical testing of the drug candidate. The development process also includes the manufacturing of the drug, regulatory approval, and commercialization.

        Browse All Tags